Cover Image
市場調查報告書

胞外體診斷、治療:全球市場

Exosome Diagnostics and Therapeutics: Global Markets

出版商 BCC Research 商品編碼 354591
出版日期 內容資訊 英文 195 Pages
訂單完成後即時交付
價格
Back to Top
胞外體診斷、治療:全球市場 Exosome Diagnostics and Therapeutics: Global Markets
出版日期: 2018年05月16日 內容資訊: 英文 195 Pages
簡介

全球胞外體產業,預計2018年達2500萬美金,此後以48.4%的年複合成長率成長,2023年達到1億8,000萬美元。

本報告提供全球胞外體診斷、治療市場相關調查,全球市場及相關技術概要,世界市場趨勢分析,新、傳統的診斷方法分析,目前治療、預測不久將來實現的治療分析,市場動態分析,及主要企業簡介等彙整。

第1章 簡介

第2章 摘要、亮點

第3章 市場、技術背景

  • 胞外體定義、用語體系
  • 胞外體的發現
  • 胞外體的生體合成、處理
  • 胞外體的零組件
  • 胞外體的分離與檢測
  • 胞外體研究、產品開發的生物資訊學資料庫
  • 胞外體的功能、生理功能

第4章 胞外體診斷市場

  • 診斷生物標記的胞外體蛋白質
  • 診斷生物標記的胞外體核酸
  • 對胞外體診斷產品開發來說有市場可能性的癌症診斷
  • 胞外體部門有診斷可能性的液態切片
  • 化驗開發的癌症生物標記的胞外體蛋白質、核酸
  • 對胞外體診斷產品開發來說有市場可能性的CNS疾病、神經退化性疾病
  • 對胞外體診斷產品開發來說有市場可能性的感染疾病
  • 對胞外體診斷產品開發來說有市場可能性的心血管疾病
  • 對胞外體診斷產品開發來說有市場可能性的產前檢查
  • 對胞外體診斷產品開發來說有市場可能性的器官移植
  • 胞外體型診斷部門的市場參與企業
    • Amarantus BioScience
    • Caris Life Sciences
    • Exosome Diagnostics
    • Exosome Sciences/Aethlon Medical
    • Exosomics Siena SPA
    • Nanosomix
    • NX Pharmagen
    • NX Prenatal
    • Orion Pharma
    • Sistemic
    • Ymir Genomics
  • 胞外體市場上目前診斷部門的評估

第5章 胞外體治療市場

  • 內因性治療活性
  • 免疫學的適合性
  • 貨物功能
  • 胞外體中介治療的生成
  • 胞外體治療的市場潛在性
  • 胞外體型治療部門的市場參與企業
    • Aegle Therapeutics
    • Aethlon Medical
    • Anjarium Biosciences
    • BioRegenerative Sciences
    • Capricor Therapeutics
    • Cell Factory
    • Codiak BioSciences
    • Creative Medical Technology Holdings (CMTH)
    • DreiRosen Pharma
    • Evox Therapeutics
    • ExoCoBio
    • ExoCyte Therapeutics
    • Exogenus Therapeutics
    • Exopharm
    • Exotech Bio
    • Exovita Biosciences
    • Intrexon Corp.
    • Kimera Labs
    • MDimune
    • MolecuVax
    • Panacea Pharmaceuticals, Inc.
    • Paradigm Pharmaceuticals
    • ReCyte
    • Regeneus
    • ReNeuron
    • Therapeutics Solutions International
    • Unicyte AG
  • 胞外體市場開發指標的臨床實驗
  • 胞外體市場上目前診斷部門的評估

第6章 胞外體試劑、研究工具市場

  • 概要
    • 分離方法、試劑
    • 檢測方法、試劑
    • 特徵化方法、試劑
    • 工程方法、試劑
    • 其他的產品、試劑
  • 市場參與企業
    • 101Bio
    • AMSBIO
    • Cell Guidance Systems
    • Ciloa
    • Evomic Science
    • Excytex
    • ExoCan
    • HansaBiomed (Lonza)
    • IZON Science
    • NanoSight (Malvern Instruments)
    • Nanoview Biosciences
    • System Biosciences (SBI)
  • 胞外體市場上目前工具、試劑的評估

第7章 特定的生物醫藥品市場相關胞外體研究的影響

  • 胞外體研究帶給生物標記、診斷產業的影響
  • 胞外體研究帶給微型核糖核酸市場的影響
  • 胞外體研究帶給液態切片市場的影響
  • 胞外體研究帶給幹細胞技術市場的影響
  • 胞外體研究帶給產前診斷市場的影響

第8章 專利檢討/新開發

第9章 市場摘要

第10章 企業簡介

BCC Research

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BIO149B

The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.

Report Includes

  • 35 data tables and 35 additional tables
  • An overview of the global markets and related technologies for exosome diagnostics and therapeutics
  • Analyses of global market trends, with data from 2016 to 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Breakdowns of new and existing diagnostic methods
  • Evaluations of current therapeutics and those likely to be utilized in the near future
  • Analyses of the market's dynamics, specifically growth drivers, restraints, and opportunities
  • Company profiles of major players in the market, including Codiak BioSciences, Evox Therapeutics, Exosome Diagnostics, Inc., HansaBioMed, NonosomiX, Inc. and System Biosciences (SBI)

Report Scope

This report represents a current and important business tool to evaluate new commercial opportunities in the exosome diagnostic, therapeutic and research tools markets. The geographic scope of this study covers the U.S. and companies worldwide. This market is complex and consists of a number of different sectors, each affected differently by scientific and technological development. The report identifies the main positive and negative factors in each sector and forecasts further trends and product and assay development in every category of this industry.

Analyst Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology and industrial assay development and drug manufacturing. She has contributed to a number of scientific publications and holds several patents. She has expertise as an assay development scientist and is familiar with different research field trends and likely future developments.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources and Methodology
  • Intended Audience
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Exosome Definition and Nomenclature
  • Discovery of Exosomes
  • Exosomes Biogenesis and Processing
  • Exosome Components
    • DNA in Exosomes
    • Proteins in Exosomes
    • RNA in Exosomes
  • Isolation and Detection of Exosomes
    • Isolation Techniques
    • Exosome Detection
  • Bioinformatics Databases for Exosome Research and Product Development
    • ExoCarta
    • Vesiclopedia
    • EVpedia
  • Exosome Function and Physiology

Chapter 4: Exosome Diagnostics Market

  • Exosomal Proteins as Diagnostic Biomarkers
  • Exosomal Nucleic Acids as Diagnostic Biomarkers
  • Cancer Diagnostics as Market Potential for Exosome-based Diagnostics Product Development..
    • Prostate Cancer as Potential for Diagnostics Development in Exosomes Sector
    • Breast Cancer as Potential for Diagnostics Development in Exosome Sector
    • Bladder Cancer as Potential for Diagnostics Development in Exosome Sector
    • Ovarian Cancer as Potential for Diagnostics Development in Exosome Sector
    • Lung Cancer as Potential for Diagnostics Development in the Exosome Sector
  • Liquid Biopsy as Potential for Diagnostics in Exosome Sector
  • Exosomal Proteins and Nucleic Acids as Cancer Biomarkers in Assay Development
  • CNS Disorders and Neurodegeneration Diseases as Market Potential for Exosome Diagnostics Product Development
  • Infectious Diseases as Market Potential for Exosome Diagnostics Product Development
  • Cardiovascular Diseases as Market Potential for Exosome Diagnostics Product Development .
  • Prenatal Testing as Market Potential for Exosome Diagnostics Product Development
  • Organ Transplantation as Market Potential for Exosome Diagnostics Product Development
  • Market Participants in Exosome-based Diagnostics Sector
    • Amarantus BioScience
    • Caris Life Sciences
    • Exosome Diagnostics
    • Exosome Sciences/Aethlon Medical
    • Exosomics Siena SPA
    • Nanosomix
    • NX Pharmagen
    • NX Prenatal
    • Orion Pharma
    • Sistemic
    • Ymir Genomics
    • Additional Exosome-based Diagnostics Market Participants
  • Evaluation of Current Diagnostics Sector in Exosome Market

Chapter 5: Exosome Therapeutic Market

  • Intrinsic Therapeutic Activity of Exosomes
  • Immunological Compatibility
  • Cargo Capabilities
  • Generation of Exosome-mediated Therapeutics
    • Exosome Isolation and Purification from Biofluids or Cell Culture
    • Engineering Exosomes as Therapeutic Delivery Vehicles
    • Targeting Exosomes to Specific Recipient Cells
    • Designing Exosomes as a Synthetic Vector
  • Market Potential for Exosome Therapeutics
  • Market Participants in Exosome-based Therapeutics Sector
    • Aegle Therapeutics
    • Aethlon Medical
    • Anjarium Biosciences
    • BioRegenerative Sciences
    • Capricor Therapeutics
    • Cell Factory
    • Codiak BioSciences
    • Creative Medical Technology Holdings (CMTH)
    • DreiRosen Pharma
    • Evox Therapeutics
    • ExoCoBio
    • ExoCyte Therapeutics
    • Exogenus Therapeutics
    • Exopharm
    • Exotech Bio
    • Exovita Biosciences
    • Intrexon Corp.
    • Kimera Labs
    • MDimune
    • MolecuVax
    • Panacea Pharmaceuticals, Inc.
    • Paradigm Pharmaceuticals
    • ReCyte
    • Regeneus
    • ReNeuron
    • Therapeutics Solutions International
    • Unicyte AG
    • Additional Pharma and Biotech Companies with Potential Exosome Research Projects
  • Clinical Trials as Indicator for Exosome Market Development
  • Evaluation of Current Therapeutics Sector in Exosome Market

Chapter 6: Exosome Reagents and Research Tools Market

  • Market Overview
    • Isolation Methodologies and Reagents for Exosome
    • Detection Methodologies and Reagents for Exosome Research
    • Characterization Methods and Reagents for Exosome Research
    • Engineering Methods and Reagents for Exosome Research
    • Additional Products and Reagents for Exosome Research
  • Market Participants for Reagents and Tools for Exosome Research
    • 101Bio
    • AMSBIO
    • Cell Guidance Systems
    • Ciloa
    • Evomic Science
    • Excytex
    • ExoCan
    • HansaBiomed (Lonza)
    • IZON Science
    • NanoSight (Malvern Instruments)
    • Nanoview Biosciences
    • System Biosciences (SBI)
    • Additional Market Participants for Reagents and Tools for Exosome Research
  • Evaluation of Current Tools and Reagents Sector in the Exosome Market

Chapter 7: Impact of Exosome Research on Specific Biopharmaceuticals Market

  • Exosome Research Impact on Biomarker and Diagnostics Industry
  • Exosome Research Impact on MicroRNA Market
  • Exosome Research Impact on the Liquid Biopsy Market
  • Exosome Research Impact on Stem Cell Technologies Market
  • Exosome Research Impact on Prenatal Diagnostic Market
  • Exosome Research Impact on Agriculture and Food Industry
  • Exosome Research, Microfluidics and Nanotechnology
  • Exosome Research Impact on Skincare Industry

Chapter 8: Patent Review/ New Developments

Chapter 9: Market Summary

Chapter 10: Company Profiles

About BCC Research

  • About BCC Research
  • BCC Library Access
  • BCC Custom Research

List of Tables

  • Summary Table: Global Market for the Exosome Industry, by Sector, Through 2023 ($ Millions)
  • Table 1 Nomenclature of Exosome Particles
  • Table 2 Publication Trend on the Subject of Exosome, 2003-2017 (No.of Publications)
  • Table 3 Steps in Exosome Biogenesis and Processing
  • Table 4 Proteins Essential in Exosome Biogenesis and Processing
  • Table 5 Proteins Found in Exosomes
  • Table 6 MicroRNA in Different Bodily Fluids
  • Table 7 Methods for Exosome Isolation
  • Table 8 Distribution of Exosomes Isolation Procedures in the Studies Cataloged in ExoCarta (%) ..
  • Table 9 Statistics of Data Cataloged in ExoCarta, 2012 and 2017 (Number)
  • Table 10 Statistics of Data Cataloged in Vesiclepedia, 2012 and 2017 (Number)
  • Table 11 Statistics of Data Cataloged in EVpedia, 2014
  • Table 12 Comparison of Databases for Exosome Studies
  • Table 13 Examples of Exosomal Proteins for Clinical Diagnostic Applications
  • Table 14 Examples of Exosomal MicroRNA for Clinical Diagnostic Applications
  • Table 15 Statistics for Prostate Cancer, 2017
  • Table 16 Global Market for Prostate Cancer Diagnostics and Related Cost ($ Billions)
  • Table 17 Statistics for Breast Cancer, 2017
  • Table 18 Global Market for Breast Cancer Diagnostics, Through 2019 ($ Billions)
  • Table 19 Statistics for Bladder Cancer, 2017
  • Table 20 Global Market for Bladder Cancer Diagnostics, 2017 ($ Billions)
  • Table 21 Statistics for Ovarian Cancer, 2017
  • Table 22 Global Market for Ovarian Cancer Diagnostics, 2017 ($ Millions)
  • Table 23 Statistics for Lung Cancer, 2017
  • Table 24 Global Market for Lung Cancer Diagnostics, 2017 ($ Millions)
  • Table 25 Liquid vs.Tissue Biopsy
  • Table 26 Global Market for Liquid Biopsy Including Research Tools, Services and Diagnostics, Through 2022 ($ Billions)
  • Table 27 Exosomal Protein Biomarkers from Body Fluids of Patients in Pre-clinical and Clinical Studies 49
  • Table 28 Exosomal Nucleic Acid Biomarkers in Pre-clinical and Clinical Studies
  • Table 29 U.S.Statistics Data for Alzheimer's, 2017 (Millions/$ Billions)
  • Table 30 Global Market for Alzheimer's Disease Therapeutics and Diagnostics, Through 2020 ($ Billions)
  • Table 31 Global Statistics Data for Hepatitis C Infection, 2015 (Millions)
  • Table 32 Global Market Value for Hepatitis C Diagnostics, 2017 ($ Billions)
  • Table 33 U.S.Statistics Data for Cardiovascular Diseases, 2017 (Number/$ Billions)
  • Table 34 Global Market for Cardiovascular Diagnostics, 2017 ($ Billions)
  • Table 35 Global Market for Prenatal Diagnostics, Predictive Tests and Neonatal Monitoring, Through 2019 ($ Billions)
  • Table 36 Global Market for Organ and Tissue Transplantation Products and Devices, Through 2020 ($ Billions)
  • Table 37 Comparison of Exosome-based Diagnostics Approach to Other Liquid Biopsy Platforms
  • Table 38 Main Market Participants in Exosome-based Diagnostics Sector
  • Table 39 Global Market for Exosome Diagnostics, Through 2023 ($ Millions)
  • Table 40 Examples of Physiological Effect of Exosome Delivery
  • Table 41 Top Five Vaccine Providers, 2016 ($ Billions)
  • Table 42 U.S.Statistics for Burn Injuries (Number/$ Billions)
  • Table 43 U.S.Statistics for Pressure Ulcer ($ Billions/Number)
  • Table 44 Revenues for Aethlon Medical, 2012-2016 ($ Millions)
  • Table 45 Revenue, Cost and Profits for Capricor Therapeutics, 2012-2016 ($ Millions)
  • Table 46 Main Market Participants in Exosome-based Therapeutics Sector
  • Table 47 Examples of Clinical Trials Related to Exosome Research
  • Table 48 Examples of Financing for Exosome-based Therapeutics Companies
  • Table 49 Global Market for Exosome Therapeutics, Through 2023 ($ Millions)
  • Table 50 Main Steps in Exosome Research Approach
  • Table 51 Examples of Commercial Kits and Reagents for Exosome Isolation
  • Table 52 Percentage of Use Each of Isolation Technique for Exosome Purification (%)
  • Table 53 Examples of Detection Assay
  • Table 54 Examples of Antibody Providers for Exosome Research
  • Table 55 Examples of RNA Extraction Commercial Kits
  • Table 56 Percentage of Use of Characterization Techniques for Exosome Sample (%)
  • Table 57 Examples of Purified Exosomes Commercial Products ($)
  • Table 58 Main Market Participants in Exosome Research Tools and Reagents
  • Table 59 Global Market for Exosome Research Tools and Reagents Market, Through 2023 ($ Millions) 162
  • Table 60 Examples of Protein Markers in Exosomes and Their Related Pathology
  • Table 61 Examples of MicroRNA Markers in Exosomes and Their Related Pathology
  • Table 62 Liquid vs.Tissue Biopsy
  • Table 63 Global Market for Prenatal Diagnostics, Predictive Tests and Neonatal Monitoring, Through 2019 ($ Billions)
  • Table 64 Number of Patents on Exosome Research Filed in Specific Years, 2000-2017
  • Table 65 Examples of Patents Filed on Exosome Research
  • Table 66 Search Analysis for Patents Using Specific Keywords (Number)
  • Table 67 Number of Patents and Patent Applications by Some Exosome Market Participants
  • Table 68 Global Market for Exosome Industry, by Application Sector, Through 2023 ($ Millions)
  • Table 69 Examples of Main Market Participants in Exosome Market

List of Figures

  • Summary Figure: Global Market for the Exosome Industry, by Sector, 2016-2023 ($ Millions)
  • Figure 1 Publication Trend on the Subject of Exosome, 2003-2017 (No.of Publications)
  • Figure 2 Differential Centrifugation Process
  • Figure 3 Ciliated Porous Device Designed to Isolate Exosomes by Filtration
  • Figure 4 Sieving Models for Exosome Filtration
  • Figure 5 Global Market for Exosome Diagnostics, 2016-2023 ($ Millions)
  • Figure 6 Global Market for Exosome Therapeutics, 2016-2023 ($ Millions)
  • Figure 7 Global Market for Exosome Research Tools and Reagents Market, 2016-2023 ($ Millions) ..
  • Figure 8 Number of Patents Filed in Specific Years on Exosome Research, 2000-2017
  • Figure 9 Search Analysis for Patents Using Specific Keywords (Number)
  • Figure 10 Global Market for Exosome Industry, by Application Sector, 2016-2023 ($ Millions) .
Back to Top